 |
|
|
| Internet Search |
|
Stock Search |
|
|
|
|
|
|
|
| |
| Company Profile |
| |
|
Genta Incorporated, a biopharmaceutical company, engages in the identification, development, and commercialization of drugs for the treatment of cancer and related diseases in the United States. Its research portfolio comprises two primary areas, DNA/RNA medicines, which include drugs that are based on chemical modifications of oligonucleotides; and small molecules. The companys lead product from the DNA/RNA medicines program is Genasense, which completed phase 3 trials in combination with chemotherapy in the treatment of malignant melanoma, chronic lymphocytic leukemia, multiple myeloma, nonsmall cell lung cancer, small cell lung cancer, and prostate cancer. Genasense inhibits production of Bcl-2, a protein made by cancer cells that is designed to block chemotherapy-induced apoptosis. Its lead product from small molecule program is Ganite, which is used for treatment of cancer-related hypercalcemia that is resistant to hydration. Gentas preclinical pipeline includes research programs in antisense, RNA interference, and decoys. In addition, the company is evaluating oral formulations of gallium-containing compounds. Genta was founded in 1988 and is based in Berkeley Heights, New Jersey.
|
GENTA INC Related |
|
Home - GENTA Genta is committed to improving the lives of patients by providing ... Genta Incorporated Copyright 2003. Driving Directions | Contact Us | Disclaimer ...
|
|
Press Releases - GENTA Genta is committed to improving the lives of patients by providing innovative solutions ... Auditors for Genta Incorporated Express Going Concern Qualification ...
|
|
GNTA - Genta Incorporated - Google Finance Get the latest on Genta Incorporated (GNTA) including up to date news, high quality discussion groups and more on Google Finance.
|
|
|
|
|
